Showing results (271-280 of 314) with videos related to

Sort By:
Pageof 32
Cancer Research Communications|December 12, 2023
Sustained Disease Control in Immune Checkpoint Blockade Responders with Microsatellite Instability-high Colorectal Cancer after Treatment TerminationKristen Simmons, Jane V Thomas, Kaysia Ludford, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|October 13, 2016
Preoperative Chemoradiation for Pancreatic Adenocarcinoma Does Not Increase 90-Day Postoperative Morbidity or MortalityJason W Denbo, Morgan L Bruno, Jordan M Cloyd, et al.
Nature Communications|October 6, 2025
Inflammation and mutational burden differentially associated with nivolumab or ipilimumab combination efficacy in colorectal cancerMing Lei, Michael J Overman, Jin Yao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 12, 2021
Clinical and Functional Characterization of Atypical KRAS/NRAS Mutations in Metastatic Colorectal CancerJonathan M Loree, Yucai Wang, Muddassir A Syed, et al.
Journal for Immunotherapy of Cancer|July 24, 2026
Impact on survival of severe immuno-related adverse events in deficient mismatch repair/microsatellite instable-high digestive cancers treated with immunotherapyDavid Tougeron, Charles Kauffmann, Margherita Ambrosini, et al.
Journal for Immunotherapy of Cancer|August 25, 2022
Phase II study of durvalumab (anti-PD-L1) and trametinib (MEKi) in microsatellite stable (MSS) metastatic colorectal cancer (mCRC)Benny Johnson, Cara L Haymaker, Edwin R Parra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 27, 2017
4-1BB Agonist Focuses CD8+ Tumor-Infiltrating T-Cell Growth into a Distinct Repertoire Capable of Tumor Recognition in Pancreatic CancerDonastas Sakellariou-Thompson, Marie-Andrée Forget, Caitlin Creasy, et al.
JAMA Surgery|July 13, 2017
Association of Clinical Factors With a Major Pathologic Response Following Preoperative Therapy for Pancreatic Ductal AdenocarcinomaJordan M Cloyd, Huamin Wang, Michael E Egger, et al.
Annals of Surgery|July 7, 2022
Prospective Study of Perioperative Circulating Tumor DNA Dynamics in Patients Undergoing Hepatectomy for Colorectal Liver MetastasesTimothy E Newhook, Michael J Overman, Yun Shin Chun, et al.
Oncotarget|May 19, 2015
Actionable mutations in plasma cell-free DNA in patients with advanced cancers referred for experimental targeted therapiesFilip Janku, Philipp Angenendt, Apostolia M Tsimberidou, et al.
Pageof 32